Daniil Gataulin
Stock Analyst at Chardan Capital
(4.11)
# 1,661
Out of 4,690 analysts
72
Total ratings
38.8%
Success rate
16.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintained: Buy | $21 → $23 | $10.36 | +122.01% | 3 | Jun 25, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $11 → $13 | $3.69 | +252.30% | 3 | Jun 17, 2026 | |
| CRVO CervoMed | Reiterated: Buy | $21 | $2.60 | +707.69% | 7 | May 17, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $36 → $35 | $13.82 | +153.26% | 2 | May 14, 2026 | |
| OCS Oculis Holding AG | Reiterated: Buy | $51 → $53 | $12.21 | +334.07% | 3 | May 12, 2026 | |
| KOD Kodiak Sciences | Upgraded: Buy | $14 → $61 | $37.72 | +61.72% | 6 | May 11, 2026 | |
| CGTX Cognition Therapeutics | Reiterated: Buy | $8 → $4 | $1.02 | +292.16% | 3 | May 8, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $5 → $7 | $1.32 | +430.30% | 8 | May 7, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $10 → $11 | $5.72 | +92.31% | 4 | May 7, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $29 | $4.48 | +547.32% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $48.72 | -24.06% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $9.66 | +438.30% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $0.6449 | +55.06% | 6 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.97 | +221.93% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $4.03 | +371.46% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.125 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.91 | n/a | 2 | Feb 15, 2023 |
Ocular Therapeutix
Jun 25, 2026
Maintained: Buy
Price Target: $21 → $23
Current: $10.36
Upside: +122.01%
Opus Genetics
Jun 17, 2026
Maintained: Buy
Price Target: $11 → $13
Current: $3.69
Upside: +252.30%
CervoMed
May 17, 2026
Reiterated: Buy
Price Target: $21
Current: $2.60
Upside: +707.69%
MeiraGTx Holdings
May 14, 2026
Reiterated: Buy
Price Target: $36 → $35
Current: $13.82
Upside: +153.26%
Oculis Holding AG
May 12, 2026
Reiterated: Buy
Price Target: $51 → $53
Current: $12.21
Upside: +334.07%
Kodiak Sciences
May 11, 2026
Upgraded: Buy
Price Target: $14 → $61
Current: $37.72
Upside: +61.72%
Cognition Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $8 → $4
Current: $1.02
Upside: +292.16%
Ocugen
May 7, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $1.32
Upside: +430.30%
Zura Bio
May 7, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $5.72
Upside: +92.31%
EyePoint
May 6, 2026
Reiterated: Buy
Price Target: $29
Current: $4.48
Upside: +547.32%
May 5, 2026
Reiterated: Buy
Price Target: $37
Current: $48.72
Upside: -24.06%
Jan 28, 2026
Reiterated: Buy
Price Target: $52
Current: $9.66
Upside: +438.30%
Jan 2, 2026
Maintained: Hold
Price Target: $3 → $1
Current: $0.6449
Upside: +55.06%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $4.97
Upside: +221.93%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $4.03
Upside: +371.46%
Jun 13, 2025
Maintained: Hold
Price Target: n/a
Current: $0.125
Upside: n/a
Feb 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $12.91
Upside: n/a